Engineering the future of drug discovery
Antiverse has raised €17M across 4 funding rounds from 17 investors, most recently a Series A round in Mar 2026. Based in Cardiff, UK; founded 2017; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2026-03-03 | Series A | €8.0M | DBW,DOMiNO Ventures,i&i Biotech Fund,Innovation Investment Capital,Kadmos Capital | View deal → |
| 2024-10-16 | Seed | €4.2M | AngelHub,Existing investors,i&i Biotech Fund I,InnoSpark Ventures,Kadmos Capital,Tensor Ventures+1 more | View deal → |
| 2023-03-01 | Other | €2.8M | AngelHub,Deep Science Ventures,Development Bank of Wales,Ed Parkinson,InnoSpark,Kadmos Capital+2 more | View deal → |
| 2021-03-30 | Other | €1.6M | UK Innovation & Science Seed Fund | View deal → |
